Scholarlink

Purpose of Review <p>Stent thrombosis (ST) is an uncommon but serious complication of percutaneous coronary intervention (PCI), associated with high morbidity, mortality, and a substantial risk of recurrence. Although its incidence has declined with contemporary drug-eluting stents (DES), outcomes remain poor. This review aims to summarize contemporary evidence on ST, including mechanism, risk factors, and management strategies to improve PCI outcomes.</p> Recent Findings <p>The risk of ST is multifactorial, influenced by patient comorbidities, lesion characteristics, procedural technique, and device-related factors. Timing after the index procedure reflects distinct mechanisms: early ST is often driven by procedural factors such as underexpansion, malapposition, or edge dissection, together with premature discontinuation of dual antiplatelet therapy (DAPT). Optical coherence tomography (OCT) studies consistently demonstrate uncovered struts, malapposition, and underexpansion as major contributors. In contrast, late and very late ST are more commonly related to impaired vessel healing, delayed endothelialization, late-acquired malapposition from vascular remodeling, and neoatherosclerosis leading to in-stent plaque rupture. Management is based largely on expert consensus, as no randomized trials have directly addressed this complication. Balloon angioplasty remains an effective option, particularly when underexpansion or malapposition are present, while additional stent implantation should generally be avoided unless needed for edge dissection or neoatherosclerosis.</p> Summary <p>Intracoronary imaging is strongly recommended, as angiography alone cannot reliably assess stent-related pathology, and imaging-guided PCI has been shown to lower ST risk. Premature cessation of DAPT, especially within the first month, is one of the strongest predictors, although many events still occur despite ongoing therapy. Future studies should focus on personalized risk prediction, further refinement of DES to reduce late complications, and long-term, mechanism-based studies to guide prevention and treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Precision Management of Coronary Stent Thrombosis: A Contemporary Guide

  • 期刊论文

  • 发表日期：

    2026年1月5日

查看全文
  • Tanawat Attachaipanich,
  • Affan Rizwan,
  • Hafeez Ul Hassan Virk,
  • Mahboob Alam,
  • Muzamil Khawaja,
  • Hani Jneid,
  • Chayakrit Krittanawong

摘要

Purpose of Review

Stent thrombosis (ST) is an uncommon but serious complication of percutaneous coronary intervention (PCI), associated with high morbidity, mortality, and a substantial risk of recurrence. Although its incidence has declined with contemporary drug-eluting stents (DES), outcomes remain poor. This review aims to summarize contemporary evidence on ST, including mechanism, risk factors, and management strategies to improve PCI outcomes.

Recent Findings

The risk of ST is multifactorial, influenced by patient comorbidities, lesion characteristics, procedural technique, and device-related factors. Timing after the index procedure reflects distinct mechanisms: early ST is often driven by procedural factors such as underexpansion, malapposition, or edge dissection, together with premature discontinuation of dual antiplatelet therapy (DAPT). Optical coherence tomography (OCT) studies consistently demonstrate uncovered struts, malapposition, and underexpansion as major contributors. In contrast, late and very late ST are more commonly related to impaired vessel healing, delayed endothelialization, late-acquired malapposition from vascular remodeling, and neoatherosclerosis leading to in-stent plaque rupture. Management is based largely on expert consensus, as no randomized trials have directly addressed this complication. Balloon angioplasty remains an effective option, particularly when underexpansion or malapposition are present, while additional stent implantation should generally be avoided unless needed for edge dissection or neoatherosclerosis.

Summary

Intracoronary imaging is strongly recommended, as angiography alone cannot reliably assess stent-related pathology, and imaging-guided PCI has been shown to lower ST risk. Premature cessation of DAPT, especially within the first month, is one of the strongest predictors, although many events still occur despite ongoing therapy. Future studies should focus on personalized risk prediction, further refinement of DES to reduce late complications, and long-term, mechanism-based studies to guide prevention and treatment.